Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate

Endocrinology

Volumn 137, Issue 7, 1996, Pages 2815-2822

  Solano, R M ^a   Carmena, M J ^a   Carrero, I ^a   Cavallaro, S ^b   Roman, F ^a   Hueso, C ^a   Travali, S ^b   Lopez Fraile, N ^a   Guijarro, L G ^a   Prieto, J C ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 8944238971     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.7.8770902     Document Type: Article

References (49)

1. Dockray G 1994 Vasoactive intestinal polypeptide and related peptides. In: Walsh JH, Dockray GJ (eds) Gut Peptides: Biochemistry and Physiology. Raven Press, New York, pp 447-472
2. Mutt V 1988 Vasoactive intestinal polypeptide and related peptides. Isolation and chemistry. Ann NY Acad Sci 527:1-19
3. Rosselin G 1994 Vasoactive Intestinal Peptide, Pituitary Adenylate Cyclase Activating Polypeptide and Related Regulatory Peptides. World Scientific, Singapore, pp 1-649
4. Magistretti PJ 1990 VIP neurons in the cerebral cortex. Trends Pharmacol Sci 11:250-254
5. Thorndyke MC, Riddell J, Thwaites DT, Dimaline R 1989 Vasoactive intestinal polypeptide and its relatives: biochemistry, distribution, and functions. Biol Bull 177:183-186
6. Crowe R, Milner P, Lincoln J, Burnstock G 1987 Histochemical and biochemical investigation of adrenergic, colinergic and peptidergic innervation of the rat ventral prostate 8 weeks after streptozotocin-induced diabetes. J Auton Nerv Syst 20:103-112
7. Lange W, Unger J 1990 Peptidergic innervation within the prostate gland and seminal vesicle. Urol Res 18:337-340
8. Tainio H 1995 Peptidergic innervation of the human prostate, seminal vesicle and vas deferens. Acta Histochem (Jena) 97:113-119
9. Crowe R, Lincoln J, Blacklay PF, Pryor JP, Lumley JSP, Burnstock G 1983 Vasoactive intestinal peptide-like immunoreactive nerves in diabetic penis. Diabetes 32:1075-1077
10. Papka RE, Cotton JP, Traurig HH 1985 Comparative distribution of neuropeptide tyrosine-, vasoactive intestinal polypeptide-, substance P-immunoreactive, acetylcholinesterase-positive and noradrenergic nerves in the reproductive tract of the female rat. Cell Tissue Res 242:475-490
11. Guijarro LG, Couvineau A, Rodriguez-Pena MS, Juarranz MG, Rodriguez-Henche N, Arilla E, Laburthe M, Prieto JC 1992 Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy. Biochem J 285:515-520
12. Haegerstrand A, Jouzon B, Dalsgaard CJ, Nilsson J 1989 Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratocytes. Proc Natl Acad Sci USA 86:5993-5996
13. Pincus DW, Dicicco-Bloom EM, Blacck IB 1990 Vasoactive intestinal polypeptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 343:564-567
14. Hoosein NM, Logothetis CJ, Chung IWK 1993 Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J Urol 149:1209-1213
15. Christophe J, Svoboda M, Lambert M, Waelbroeck M, Winand J, Dehaye JP, Vandermeers MC, Robberecht P 1986 Effector mechanisms of peptides of the VIP family. Peptides [Suppl 1] 7:101-107
16. O'Dorisio MS 1987 Biochemical characteristics of receptors for vasoactive intestinal polypeptide in nervous, endocrine and immune systems. Fed Proc 46:192-195
17. Carmena MJ, Prieto JC 1983 Cyclic AMP-stimulating effect of vasoactive intestinal peptide in isolated epithelial cells of rat ventral prostate. Biochim Biophys Acta 763:414-418
18. Prieto JC, Carmena MJ 1983 Receptors for vasoactive intestinal peptide on isolated epithelial cells of rat ventral prostate. Biochim Biophys Acta 763:408-413
19. Carmena MJ, Sancho JI, Prieto JC 1986 Effects of age and androgens upon functional vasoactive intestinal peptide receptors in rat prostatic epithelial cells. Biochim Biophys Acta 888:338-343
20. Juarranz MG, Guijarro LG, Bajo AM, Carmena MJ, Prieto JC 1994 Ontogeny of vasoactive intestinal peptide receptors in rat ventral prostate. Gen Pharmacol 25:509-514
21. Carmena MJ, Clemente C, Guijarro LG, Prieto JC 1992 The effect of streptozotocin diabetes on the vasoactive intestinal peptide receptor/effector system in membranes from rat ventral prostate. Endocrinology 131:1993-1998
22. Glynn RJ, Campion EW, Bouchard GR, Silbert JE 1985 The development of bening prostatic hyperplasia among volunters in the normative aging study. Am J Epidemiol 121:78-82
23. Chapple CR, Crowe R, Gilpin SA, Gosling J, Burnstock G 1991 The innervation of human prostate gland. The changes associated with benign enlargement. J Urol 146:1637-1644
24. Laburthe M, Rousset M, Boissard C, Chevalier G, Zweibaum A, Rosselin G 1978 Vasoactive intestinal peptide: a potent stimulator of adenosine 3′: 5′ cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci USA 75:2772-2775
25. Bradford M 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein binding. Anal Biochem 72:248-254
26. Ogi K, Kimura C, Onda H, Arimura A, Fujino M 1990 Molecular cloning and characterization of rat pituitary adenylate cyclase activating polypeptide (PACAP). Biochem Biophys Res Commun 173: 1271-1279
27. Couvineau A, Rouyer-Fesssard C, Darmoul D, Maoret JJ, Carrero I, Ogier-Denis E, Laburthe M 1994 Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem Biophys Res Commun 200:769-776
28. Svoboda M, Tastenoy M, Van Rampelbergh J, Grossens JF, DeNeef P, Waelbroeck M, Robberecht P 1994 Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem Biophys Res Commun 205:1667-1624
29. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
30. Houslay MD, Metcalfe JC, Warren GB, Hesketh TR, Smith GA 1976 The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it. Biochim Biophys Acta 436:489-494
31. Gilman AG 1970 A protein binding assay for adenosine 3′:5′ cyclic monophosphate. Proc Natl Acad Sci USA 67:305-312
32. Scatchard G 1949 The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660-672
33. Munson P, Rodbard D 1980 LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239
34. Rodriguez-Henche N, Rodriguez-Pena MS, Guijarro LG, Prieto JC 1994 Characterization of vasoactive intestinal peptide receptors in human liver. Biochim Biophys Acta 1221:193-198
35. Salomon RA, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallee D, Blais A, Darmoul D, Laburthe M 1993 Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. Am J Physiol 264:E294-E300
36. Christophe J 1993 Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim Biophys Acta 1154:183-199
37. Gottschall PE, Tatsuno I, Arimura A 1991 Hypothalamic binding sites for pituitary adenylate cyclase-activating polypeptide (PACAP): characterization and molecular identification. FASEB J 5:94-199
38. Hamer T, Lutz E 1994 Multiple receptors for PACAP and VIP. Trends Pharmacol Sci 15:97-99
39. Inagaki N, Yoshida H, Mizuta M, Mizuno N, Fujii Y, Gonoi T, Miyazaki JI, Seino S 1994 Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secretin cells. Proc Natl Acad Sci USA 91:2679-2683
40. 2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 1:3-8
41. Laburthe M, Couvineau A 1988 Molecular analysis of vasoactive intestinal peptide receptors. A comparison with receptors for VIP-related peptides. Ann NY Acad Sci 527:296-313
42. Rosselin G 1986 The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity. Peptides [Suppl 1] 7:89-100
43. Couvineau A, Laburthe M 1985 The human vasoactive intestinal peptide receptor: molecular identification by covalent cross-linking in colonic epithelium. J Clin Endocrinol Metab 61:50-55
44. Fabre C, El Battari A, Karamanos Y, Couvineau A, Laburthe M, Marvaldi J, Pichon J, Luis J 1992 Contribution of the oligosaccharide moiety to the heterogeneity of VIP receptors. Biomed Res [Suppl 2] 13:107-114
45. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S 1992 Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-819
46. Couvineau A, Rouyer-Fesssard C, Voisin T, Laburthe M 1990 Functional and immunological evidence for stable association of solubilized vasoactive intestinal peptide receptor and stimulatory nucleotide binding protein from rat liver. Eur J Biochem 187:605-609
47. s in lung membranes. J Biol Chem 267:3382-3388
48. Birnbaumer L 1990 G proteins in signal transduction. Annu Rev Pharmacol Toxicol 30:675-705
49. Vaalasti A, Tainio H, Pelto-Huikko M, Hervonen A 1986 Light and electron microscope demonstration of VIP- and enkephalin-immunoreactive nerves in the human male genitourinary tract. Anat Rec 215:21-27